Trial Profile
Exposure, Safety and Local Tolerance Study Comparing the Relative Bioavailability of Oral Methotrexate and the VIBEX™ MTX Device in Adult Subjects With Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Registrational
- 09 Nov 2015 Results from this trial were presented at the Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy Strategies session to be held during the 2015 Annual Meeting of the American College of Rheumatology, according to an Antares Pharma media release.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2012 Profile updated with data presented in an Antares Pharma media release.